BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND STRN, ENSG00000115808, 6801, O43815, SG2NA, MGC125642
6 results:

  • 1. Kharameh cohort study (KHCS) on non-communicable diseases and preliminary findings of 3-year follow-up.
    Rezaianzadeh A; Niazkar HR; Rezaeianzadeh R; Jafari F; Rahimikazerooni S; Ghoddusi Johari M; Zare M; Hosseini SV
    BMJ Open; 2024 Feb; 14(2):e077116. PubMed ID: 38331866
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparison between oxaliplatin therapy and capecitabine monotherapy for high-risk stage II - III elderly patients with colon cancer.
    Park J; Baik H; Kang SH; Seo SH; Kim KH; Oh MK; Lee HS; Lee SH; Kim KH; An MS
    Asian J Surg; 2022 Jan; 45(1):448-455. PubMed ID: 34364765
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. colorectal Adenocarcinomas Harboring ALK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 12 Cases and Review of the Literature.
    Lasota J; Chłopek M; Wasąg B; Kowalik A; Christiansen J; Lamoureux J; Kuźniacka A; Felisiak-Gołąbek A; Liu Y; Reyes TAR; Saha R; Agaimy A; Behenska K; Biernat W; Cattaneo L; Centonze G; Daum O; Daumova M; Domagała P; Dziuba I; Geppert CE; Góźdź S; Nasierowska-Guttmejer A; Hałoń A; Hartmann A; Inaguma S; Iżycka-Świeszewska E; Kaczorowski M; Kołos M; Kopczyński J; Michal M; Milione M; Okoń K; Pęksa R; Pyzlak M; Ryś J; Waloszczyk P; Wejman J; Miettinen M
    Am J Surg Pathol; 2020 Sep; 44(9):1224-1234. PubMed ID: 32804454
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integrative analysis of oncogenic fusion genes and their functional impact in colorectal cancer.
    Choi Y; Kwon CH; Lee SJ; Park J; Shin JY; Park DY
    Br J Cancer; 2018 Jul; 119(2):230-240. PubMed ID: 29955133
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Detection of an
    Lai AZ; Schrock AB; Erlich RL; Ross JS; Miller VA; Yakirevich E; Ali SM; Braiteh F
    Oncologist; 2017 Jul; 22(7):774-779. PubMed ID: 28507204
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Oncogenic ALK Fusion in Rare and Aggressive Subtype of colorectal Adenocarcinoma as a Potential Therapeutic Target.
    Yakirevich E; Resnick MB; Mangray S; Wheeler M; Jackson CL; Lombardo KA; Lee J; Kim KM; Gill AJ; Wang K; Gowen K; Sun J; Miller VA; Stephens PJ; Ali SM; Ross JS; Safran H
    Clin Cancer Res; 2016 Aug; 22(15):3831-40. PubMed ID: 26933125
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.